First clinical use of a novel bioartificial liver support system (BLSS).
about
Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantationAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes.Position paper of the Ethics Committee of the International Xenotransplantation Association.The year in review--ATC 2002.Hepatocyte hollow-fibre bioreactors: design, set-up, validation and applications.Systematic review: extracorporeal bio-artificial liver-support system for liver failure.A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems.History of xenotransplantation.Technology insight: liver support systems.Bioreactors for extracorporeal liver support.Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patientsBioartificial liver systems: why, what, whither?Extracorporeal liver support.Liver tissue engineering and cell sources: issues and challenges.Extracorporeal support for patients with acute and acute on chronic liver failure.Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells.Bifunctional polyethersulfone hollow fiber with a porous, single-layer skin for use as a bioartificial liver bioreactor.Intracranial pressure observations in a canine model of acute liver failure supported by a bioartificial liver support system.BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen.Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.Effect of membranes on oxygen transfer rate and consumption within a newly developed three-compartment bioartificial liver device: Advanced experimental and theoretical studies.Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.
P2860
Q27001113-7069F9DE-32DC-4B95-A8F0-6FBE53B28E4EQ30234560-6E39E192-D514-4EAD-B087-48D326DFE8FAQ33237089-882F6CBC-D6B0-4503-81CA-58B8776AAB63Q34190490-2184D2E9-E066-4219-8AAF-46C7C75E095FQ35106639-675EF193-5FFB-44D3-B2DF-59B1B40331B6Q35578597-62E2FD0A-890A-487B-9696-1C8AB743F89DQ35706287-667E62D9-E8C6-45B9-BD83-C7221EC8671EQ35913437-5051CFF8-9AF9-46BE-B242-8961BB94F131Q36031618-5A7CFCB3-F2A3-43C2-9287-7EE93CC5E3AAQ36304257-9510FC91-8610-4564-952F-B2E279F3D73FQ36530003-199FE2A3-F8E4-4723-BD89-EB2661360E70Q36802514-292FABB9-3BAA-4743-B268-5DA893CD16E0Q37202810-9C2E64F3-8243-41DE-A291-1EB06DB42B86Q38055288-59ECAAE6-E43D-4C3E-A374-B77D714D3A71Q38089346-40D310E4-5CFD-4252-9BBF-C2DD66A76B7EQ38740963-F1BB76EB-5BFA-408B-9DA7-D1054D152D75Q39217787-898F2A90-A0C1-40F2-BE9F-F30031FACC39Q39348395-84F12B51-3D99-43AE-9247-6D5138561197Q44844495-CC424025-A00C-46C4-9E80-104A5EEC6503Q45171054-8B33D0E2-34A6-42CF-8C6F-C086DA48DBE8Q46170293-A858CEA8-D660-427C-A122-4C2631074CEAQ51147609-CA5429F0-9583-449B-A499-B9705BA73037Q53155879-6BA38E49-B96B-4548-A1B7-00215879EAB2
P2860
First clinical use of a novel bioartificial liver support system (BLSS).
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
First clinical use of a novel bioartificial liver support system (BLSS).
@ast
First clinical use of a novel bioartificial liver support system (BLSS).
@en
type
label
First clinical use of a novel bioartificial liver support system (BLSS).
@ast
First clinical use of a novel bioartificial liver support system (BLSS).
@en
prefLabel
First clinical use of a novel bioartificial liver support system (BLSS).
@ast
First clinical use of a novel bioartificial liver support system (BLSS).
@en
P2093
P2860
P1476
First clinical use of a novel bioartificial liver support system (BLSS).
@en
P2093
Bruce P Amiot
David J Kramer
John F Patzer
Mauricio Giraldo
Melissa L Fulmer
Michael E Devera
Roberto C Lopez
Tracy A Grogan
P2860
P304
P356
10.1034/J.1600-6143.2002.20311.X
P407
P577
2002-03-01T00:00:00Z